Synthetic Design Of Coumarin And 2H-Chromene-2-Thione Derivatives To Inhibit Carcinogenesis by Haywood, Rhashanda D.
North Carolina Agricultural and Technical State University 
Aggie Digital Collections and Scholarship 
Theses Electronic Theses and Dissertations 
2013 
Synthetic Design Of Coumarin And 2H-Chromene-2-Thione 
Derivatives To Inhibit Carcinogenesis 
Rhashanda D. Haywood 
North Carolina Agricultural and Technical State University 
Follow this and additional works at: https://digital.library.ncat.edu/theses 
Recommended Citation 
Haywood, Rhashanda D., "Synthetic Design Of Coumarin And 2H-Chromene-2-Thione Derivatives To 
Inhibit Carcinogenesis" (2013). Theses. 301. 
https://digital.library.ncat.edu/theses/301 
This Thesis is brought to you for free and open access by the Electronic Theses and Dissertations at Aggie Digital 
Collections and Scholarship. It has been accepted for inclusion in Theses by an authorized administrator of Aggie 
Digital Collections and Scholarship. For more information, please contact iyanna@ncat.edu. 
Synthetic Design of Coumarin and 2H-chromene-2-thione Derivatives to Inhibit Carcinogenesis 
Rhashanda D. Haywood 
North Carolina A&T State University 
 
 
 
 
 
A thesis submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
Department: Chemistry 
Major: Chemistry 
Major Professor:  Dr. Marion A. Franks 
Greensboro, North Carolina 
2013
i 
 
School of Graduate Studies 
North Carolina Agricultural and Technical State University 
This is to certify that the Master’s Thesis of 
 
Rhashanda D. Haywood 
 
has met the thesis requirements of 
North Carolina Agricultural and Technical State University 
 
Greensboro, North Carolina 
2013 
 
Approved by: 
 
  
 
Dr. Marion Franks 
Major Professor 
 
Dr. Julius Harp 
Committee Member 
 
Dr. Mufeed Basti 
Committee Member 
 
Dr. Sanjiv Sarin 
Dean, The Graduate School 
 
Dr. Margaret Kanipes 
Department Chair 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Copyright by 
Rhashanda D. Haywood 
2013 
 
iii 
 
Biographical Sketch 
            Rhashanda Haywood was born on July 6, 1987 in Spartanburg, SC. In 2009, she received 
her Bachelor’s degree in Chemistry from Johnson C. Smith University in Charlotte, NC. After 
graduating from Johnson C. Smith University, she worked for Duke Energy at their McGuire 
Nuclear Station as a lab technician in the Central Fuels Laboratory. In the fall of 2010, she 
became a candidate in pursuit of a Master’s Degree in Chemistry at North Carolina Agricultural 
and Technical State University. In the fall of 2011, she became a charter member for the Iron 
chapter of Iota Sigma Pi an Honors society for Women in Chemistry. She conducted research 
under the direction of Dr. Marion A. Franks on the Synthesis and chemopreventive activity of 
coumarin and 2H-Chromene-2-thione derivatives during her attendance at North Carolina A&T 
State University.  
 
iv 
 
Dedication 
            I would like to dedicate this thesis to my intermediate family; to my parents Rosa Dunlap, 
and the late Albert Dunlap and my brother Donovan Haywood. I thank my parents for giving me 
life, and I thank my mother and brother for the continuous words of encouragement, for 
supporting me in what I am striving to accomplish, and for the unconditional love. 
 
 
v 
 
Acknowledgements 
             I would like to start by acknowledging God, because without his grace and mercy 
nothing I attempt to achieve would be possible. I would like to thank my advisor, Dr. Marion A. 
Franks, for all his guidance throughout my tenure at North Carolina Agricultural and Technical 
State University. Without his compassion and acts of kindness on my behalf, I don’t know how I 
would have made it through. I would like to thank Ms. Carolyn Mayo for everything she has ever 
done for me. She has truly been a second mother to me. I would also like to thank Mr. Zadok 
Abrahaim, Carlos Crawford and Mr. James King, for aiding me in utilizing instrumentation for 
my compounds, and Ms. Joyce Njoroge and Mr. Charles Wilson, for helping me in providing the 
items needed to complete my research.  
            I thank my parents for giving me life, and I thank my mother and brother for the 
continuous words of encouragement, for supporting me in what I am striving to accomplish, and 
for the unconditional love. To my cousin Talisha Haywood, I thank her for making my transition 
to North Carolina A&T State University a smooth one. I thank my research group members, 
Davia McKoy, Brittany Nichols, Courtney Peace, Jasmine Fluker, Jonathan Moseley, Shaylon 
Johnson and past group members. I thank all of my other colleagues in the chemistry department 
for their encouragement, help, and support throughout my academic endeavors. I would also like 
to thank my committee for reviewing my thesis. 
  
 
  
vi 
 
Table of Contents 
List of Figures ................................................................................................................................. x 
List of Tables ................................................................................................................................. xi 
List of Schemes ............................................................................................................................. xii 
Nomenclature ............................................................................................................................... xiii 
Abstract ........................................................................................................................................... 2 
CHAPTER 1 Introduction............................................................................................................... 3 
1.1 Cancer Statistics ........................................................................................................................ 3 
1.1.1 Mechanism of cancer. ............................................................................................................ 3 
      1.1.1.1 Tumor surpressor genes and oncogenes ....................................................................... 4 
         1.1.1.1.1 The application of cancer chemoprevention. .......................................................... 6 
CHAPTER 2 Literature Review ..................................................................................................... 9 
2.1 Naturally Occuring Coumarins ................................................................................................. 9 
2.1.1 Coumarins in foods ................................................................................................................ 9 
2.1.2 Coumarins in plants ............................................................................................................. 10 
2.1.3 Coumarins for medicinal use ............................................................................................... 10 
2.2 Synthesis of Coumarin Derivatives ........................................................................................ 10 
2.3 Synthesis of 2H-Chromene-2-Thiones ................................................................................... 13 
2.3.1 Lawesson’s reagent. ............................................................................................................. 13 
2.4 Michael Acceptors. ................................................................................................................. 14 
2.5 2H-Chromene-2-Thione Derivatives as Chemopreventive Agents. ....................................... 16 
vii 
 
CHAPTER 3 Methodology ........................................................................................................... 19 
3.1 Experimental ........................................................................................................................... 19 
3.1.1 Materials and methods. ........................................................................................................ 19 
3.1.2 Characterization of compounds . ......................................................................................... 19 
3.2 Synthesis of Coumarin Derivatives ........................................................................................ 19 
3.2.1 Synthesis of 7-hydroxy-4-methylcoumarin (3) .................................................................... 20 
3.2.2 Synthesis of 7-hydroxy-4,8-dimethylcoumarin (4) .............................................................. 20 
3.2.3 Synthesis of 6-chloro-7-hydroxy-4-methylcoumarin (5) ..................................................... 20 
3.2.4 Synthesis of 6-n-dodecyl-7-hydroxy-4-methylcoumarin (6) ............................................... 21 
3.2.5 Synthesis of  7,8-dihydroxy-4-methylcoumarin (7)............................................................. 21 
3.2.6 Synthesis of  7-methoxy-4-methylcoumarin (8) .................................................................. 21 
3.2.7 Synthesis of  5,7-dihydroxy-4-methylcoumarin (9)............................................................. 21 
3.2.8 Synthesis of  5-hydroxy-4,7-dimethylcoumarin (10)........................................................... 21 
3.2.9 Synthesis of  7-methoxy-4-methylcoumarin (11) ................................................................ 22 
3.3 Synthesis of Coumarin Derivatives with ZrCl4 ...................................................................... 22 
3.3.1 Synthesis of  7,8-dihydroxy-4-methylcoumarin (12)........................................................... 22 
3.3.2 Synthesis of  7-hydroxy-4-methylcoumarin (13) ................................................................. 22 
3.3.3 Synthesis of  5-hydroxy-4,7-dimethylcoumarin (14)........................................................... 23 
3.3.4 Synthesis of  6-chloro-7-hydroxy-4-methylcoumarin (15) .................................................. 23 
3.3.5 Synthesis of  7-hydroxy-4-methylcoumarin (16) ................................................................. 23 
viii 
 
3.4 Synthesis of  TBDMS Coumarin Derivatives ......................................................................... 23 
3.4.1 Synthesis of  7-tbdms-4,8-dimethylcoumarin (17) .............................................................. 23 
3.4.2 Synthesis of  5,7-(tbdms)2-4-methylcoumarin (18) ............................................................. 24 
3.4.3 Synthesis of  5-tbdms-4,7-dimethylcoumarin (19) .............................................................. 24 
3.4.4 Synthesis of  6-n-dodecyl-7-tbdms-4-methylcoumarin (20) ................................................ 24 
3.4.5 Synthesis of  7,8-(tbdms)2-4-methylcoumarin (21) ............................................................. 25 
3.5 Synthesis of 2H-Chromene-2-Thione Derivatives .................................................................. 25 
3.5.1 Synthesis of  7-hydroxy-4-methyl-2h-chromene-2-thione (3a) ........................................... 25 
3.5.2 Synthesis of  7-hydroxy-4,8-dimethyl-2h-chromene-2-thione (4a) ..................................... 25 
3.5.3 Synthesis of  7-tbdms-4,8-dimethyl-2h-chromene-2-thione (4b) ........................................ 26 
3.5.4 Synthesis of  6-chloro-7-hydroxy-4-methyl-2h-chromene-2-thione (5a) ............................ 26 
3.5.5 Synthesis of  6-n-dodecyl-7-hydroxy-4-methyl-2h-chromene-2-thione (6a) ...................... 26 
3.5.6 Synthesis of  7,8-dihydroxy-4-methyl-2h-chromene-2-thione (7a) ..................................... 27 
3.5.7 Synthesis of  7-methoxy-4-methyl-2h-chromene-2-thione (8a) .......................................... 27 
3.5.8 Synthesis of  5,7-dihydroxy-4-methyl-2h-chromene-2-thione (9a) ..................................... 28 
3.5.9 Synthesis of  5-hydroxy-4,7-dimethyl-2h-chromene-2-thione (10a) ................................... 28 
CHAPTER 4 Results and Discussion ........................................................................................... 29 
4.1 Discussion ............................................................................................................................... 29 
4.1.1 Mechanism of the von pechmann condensation .................................................................. 29 
4.1.2 Comparison of lewis acid catalysts. ..................................................................................... 30 
ix 
 
4.2 Discussion of TBDMS Coumarin Derivatives. ...................................................................... 32 
4.2.1 Tertbutyldimethylsilyloxy (tbdms) coumarin derivatives. .................................................. 32 
4.3 Expected Coumarin NMR Spectra ......................................................................................... 34 
4.3.1 Expected thione spectra . ..................................................................................................... 34 
4.3.2 Discussion of the 7-hydroxy-4-methylcoumarin spectra ..................................................... 35 
4.3.3 Discussion of the thione spectra .......................................................................................... 38 
4.3.4 Discussion of the carbon 13 spectra of coumarin . .............................................................. 42 
4.3.5 Discussion of the thione carbon 13 spectra .......................................................................... 45 
4.4 Discussion of the IR Spectra. .................................................................................................. 46 
4.4.1 Infrared spectra interpretation. ............................................................................................. 46 
CHAPTER 5 Discussion and Future Research ............................................................................. 48 
References ..................................................................................................................................... 50 
Appendix A .................................................................................................................................... 54 
Appendix B .................................................................................................................................... 59 
  
  
x 
 
List of Figures 
Figure 1. Mechanism of cancer (Tannock, 2005) ........................................................................... 3 
Figure 2. How cancer chemoprevention works.. ............................................................................ 7 
Figure 3. Structures of some naturally occuring coumarins ........................................................... 9 
Figure 4. Structure of Lawesson’s reagent ................................................................................... 13 
Figure 5. Structure of 2H-chromene-2-one and thione ................................................................. 16 
Figure 6. Expected NMR chemical shifts ..................................................................................... 34 
Figure 7. 
1
H NMR spectra of 7-hydroxy-4-methylcoumarin........................................................ 35 
Figure 8. 
1
H NMR spectra of the aromatic region of 7-hydroxy-4-methylcoumarin ................... 36 
Figure 9.
 1
H NMR spectra of the allylic hydrogen chemical shift of 7-hydroxy-4-methylcoumarin
....................................................................................................................................................... 37 
Figure 10. 
1
H NMR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione ............................... 38 
Figure 11. Aromatic region of the 
1
H NMR spectra of 7-hydroxy-4-methyl-2H-chromene-2-
thione............................................................................................................................................. 39 
Figure 12. 
1
H NMR spectra of the allylic hydrogen chemical shift.............................................. 40 
Figure 13. 
13
C NMR spectra of 7-hydroxy-4,8-dimethylcoumarin (Karimi & Zareyee, 2008) ... 44 
Figure 14. 
13
C NMR spectra of 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione ....................... 45 
Figure 15. IR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione ......................................... 47 
 
 
 
 
 
xi 
 
List of Tables 
Table 1 Different Classes of Cancer Chemopreventive Agents ................................................... 14 
Table 2 Pecent yields of InCl3 and ZrCl4 Catalyzed procedure .................................................... 31 
Table 3 Percent Yields of the Protected Coumarins ..................................................................... 33 
Table 4 Vinylic, Allylic and Phenolic 
1
H Chemical Shifts ........................................................... 41 
Table 5 Vinylic, Allylic and Carbonyl Carbon 
13
C Chemical Shifts ............................................ 43 
Table 5 Cont .................................................................................................................................. 44 
Table 6  Variance of the C=S Peaks ............................................................................................. 46 
xii 
 
List of Schemes 
 
Scheme 1. Various synthetic routes to obtain coumarin derivatives ............................................ 11 
Scheme 2. General synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione ............................. 12 
Scheme 3. General synthesis of 2H-chromene-2-thione............................................................... 14 
Scheme 4. Michael adduct formation ........................................................................................... 15 
Scheme 5. Synthesis of 7-hydroxy-4-methylcoumarin ................................................................. 19 
Scheme 6. Synthesis of 7,8-dihydroxy-4-methylcoumarin ........................................................... 22 
Scheme 7. Synthesis of  7-TBDMS-4,8-dimethylcoumarin ......................................................... 23 
Scheme 8. Synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione .......................................... 25 
Scheme 9. Mechanism of Von Pechmann condensation .............................................................. 29 
 
  
xiii 
 
Nomenclature 
13
C NMR Carbon  ........................................... Carbon Nuclear Magnetic Resonance Spectroscopy 
CH2Cl2 .............................................................................................................. Methylene Chloride 
DI  ......................................................................................................................... De-Ionized Water 
DMSO .............................................................................................................. Di-methyl Sulfoxide 
EtOH ..................................................................................................................................... Ethanol 
Et3N ........................................................................................................................... Tri-ethylamine 
InCl3 .................................................................................................................. Indium(III)Chloride 
IR.................................................................................................................... Infrared Spectroscopy 
Na2SO4 ...................................................................................................................... Sodium Sulfate 
THF ......................................................................................................................... Tetrahydrofuran 
TLC ..................................................................................................... Thin Layer Chromatography 
TBDMSCl ................................................................................. Tertiarybutyldimethylchloro silane 
ZrCl4 .................................................................................................. Zirconium(IV) Tetra Chloride 
2 
 
Abstract 
The goal of this project was the synthesis of 4-substitued coumarins and 2H-chromene-2-thione 
derivatives that can be used to inhibit or retard the growth of cancer cells. According to the 
American Cancer Society’s 2012 death statistics for prostate cancer, 28,170 men died from 
prostate cancer and there was 241,740 (29%) new cases of prostate cancer as well (Society, 
2012). Few studies have been conducted on 2H-chromene-2-thiones and their ability to act as 
cancer chemopreventive or anticancer agents, therefore, we seek to synthesize a sequence of 
coumarins and 2H-chromene-2-thiones via the Von Pechmann reaction. We believe that the 2H-
chromene-2-thiones will exhibit better chemopreventive activity then the analogous coumarins 
because of the presence of the softer sulfur atom. The syntheses of the coumarin derivatives in 
this study were accomplished using green chemistry. The indium chloride catalyzed Von 
Pechmann condensation required no solvent and formed coumarins efficiently. Upon 
synthesizing coumarins, they were converted into their 2H-chromene-2-thione analogs using 
Lawesson’s reagent. Percent yields of the coumarin derivatives range from 40% to 80%. The 2H-
chromene-2-thione percent yields range from 11% to 61%.  
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CHAPTER 1 
Introduction 
1.1 Cancer Statistics 
According to the American Cancer Society, the number of new cases of cancer in 2011 
was an estimated 1,596,670 (Society, 2011). This is an increase of 67,110 from 2010, and an 
increase of 117,320 from 2009.  American Cancer Society’s death statistics for Cancer shows 
that more than half a million individuals died from Cancer in 2011 (571,950) which is more than 
1500 persons a day (Society, 2011). This is an overall increase of 12,070 deaths from Cancer in 
the past three years, (569,490 in 2010, and 562,340 in 2009)(Society, 2009, 2010).  
1.1.1 Mechanism of cancer. Carcinogens are compounds that initiate tumor 
development and during the initiation phase (the first stage of carcinogenesis), the carcinogen 
interacts with DNA in the cell. Ultra-violet radiation, viruses, television waves, and microwaves; 
even down to the foods that we eat, and how they are prepared can allow for the development of 
cancerous tumors. (Alomirah et al., 2011)  Carcinogenesis has four stages: Initiation, promotion, 
progression, and finally malignant conversion (Tannock, 2005).  
 
Figure 1. Mechanism of cancer (Tannock, 2005). 
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Figure one illustrates the mechanism of how cancer develops and causes damage to 
normal cells. During each stage of cancer, there is a genetic change that takes place. A 
carcinogen damages the DNA sequencing and creates a break in the DNA strand (Tannock, 
2005). However, during initiation the mechanisms to allow cellular repair and apoptosis 
promotion are still functioning. During the promotion phase, in the cell cycle phase (M phase) 
the damaged genome is copied to a new daughter cell (Tannock, 2005). When an individual has 
prolonged exposure to the carcinogen, kinases (proteins) called promoters, are overexpressed. 
This increase in expression levels promotes the formation of tumors/lesions that are benign at 
this stage. Because the cancerous tumors have yet to progress to the final stage of carcinogenesis, 
apoptosis of the cell (programmed cell death) can occur and damage that occurred at this stage 
can be overturned. From the repeating of the first two stages, initiation and promotion, there is 
transformation of the tumor from benign to neoplastic. This is said to be progression, the third 
stage in carcinogenesis (Tannock, 2005). Malignant conversion is the final stage of cancer. In 
this stage, the cells divide and grow uncontrollably because of expression of the neoplastic 
phenotype. This process will allow for the development of malignant tumors (Tannock, 2005). 
1.1.1.1 Tumor suppressor genes and oncogenes. During carcinogenesis oncogenes and 
tumor suppressor genes are altered. The difference between an oncogene and a tumor suppressor 
gene is that an oncogene is mutational activation of proteins that normally promote cell 
proliferation (Weinberg, 2007). A tumor suppressor gene is mutational inactivation of proteins 
that normally inhibits cell proliferation. During the cell cycle, if a cell is found to have any 
damage, the tumor suppressor genes normally repair the damage. However, if the damage is 
beyond repair the tumor suppressor genes will signal for the cell to undergo apoptosis.  If there 
are mutations in the tumor suppressor genes, the signaling of the cells to undergo apoptosis will 
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not occur and the cells will continue to proliferate. An oncogene promotes cancer growth and 
transforms cells from a normal state to a cancerous state. Oncogenes are different from tumor 
suppressor genes with the loss of function such as unregulated activation of the oncogenes to 
promote a cell to proliferate even though it has mutations within itself (Weinberg, 2007).  With 
the oncogene’s gain of a function it can initiate cancer development. An example of a proto-
oncogene that can undergo transformation into an oncogene is Src. Src is a kinase that 
phosphorylates substrates. When there is a mutation of Src it becomes v-src (viral-Src) and may 
cause proliferation of cells (Weinberg, 2007).  
Tumor suppressors are defensive genes that restrict the growth of tumors. Cancer can 
develop if the tumor suppressor loses its function. An example of a tumor suppressor is 
Adenomatous Polyposis Coli (APC) and p53. Tumor suppressor gene, p53 serves as the 
“security” of the cell as it keeps everything in order. If p53 receives information about genetic 
damage or a metabolic disorder within a cell it may delay the cell going into the next phase of 
the cell cycle (Weinberg, 2007). If the damage is beyond repair, p53 can signal for the cell to 
undergo apoptosis. However if there is a mutation within p53 this disables the genes ability to 
function in its normal capacity. A mutation in p53 can bring about prostate cancer in men, and a 
mutation in APC can bring about colon cancer in 70% of sporadic cases of the disease 
(Weinberg, 2007). In terms of sporadic cases of cancer development, according to the multi-hit 
theory of cancer development Scientist Alfred Knudson hypothesized that cancer is brought 
about from a “series” of mutations and not a single mutation (Weinberg, 2007). In 1987, 
Knudson conducted a study on children with retinoblastoma to prove his hypothesis to be 
correct. Knudson’s observations showed that there were two distinct categories of patients, 
patients who had family members with retinoblastoma (familial form), and the other category is 
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those who did not have a family history of retinoblastoma (sporadic form). Those who developed 
the sporadic form of retinoblastoma only developed a tumor in one eye. But the patients who 
developed the familial form developed a tumor in both eyes. If an individual has mutations in a 
specific gene, then this is probable cause for tumor development. Using the retinoblastoma case 
as an example, an individual had to inherit a mutated gene. Hence, mutations in both copies of a 
gene are needed for the retinoblastoma gene to initiate tumor development. However in the 
sporadic form, the tumor develops over a period of time, because only one gene mutation is 
inherited in the familial form. The multi-hit theory is also inclusive of the fact that cancer 
development is driven by not only the deactivation of tumor suppressor genes, but also the 
activation of proto-oncogenes. 
1.1.1.1.1 The application of cancer chemoprevention. Cancer chemoprevention is the use 
of chemical compounds or dietary components either to protect against the initiation of 
carcinogenesis or stop the growth of a cancerous tumor. Figure 2 provides a schematic of the 
biological approach to preventing cancer. As previously stated in the multi hit theory of cancer 
development, before a carcinoma develops, there are a series of events that leads to this 
development. This development can be caused by abnormalities in several biological 
mechanisms. During carcinogenesis, there are several pathways that can lead to cancer. Figure 2 
illustrates three of the numerous pathways to cancer formation, which are antiapoptosis, growth 
factors, and proangiogenesis. Ras, an oncogene, and Rb, a tumor suppressor gene, when altered 
can bring about cancer. EGF, VEGF, and BFGF are growth factors. When there is an imbalance 
in these growth factors, this mutation can accelerate the transformation of a normal cell into a 
cancerous cell (Tsao, Kim, & Hong, 2004). Therefore, cancer chemoprevention can be applied to 
inhibit or halt the abnormal signaling of tumor suppressor/oncogenes, growth factors as well as 
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other biological factors such as deregulation of enzymes (telomerase activity) and pathways 
(cyclooxygenase pathway) (Tsao et al., 2004). Figure 2 shows three different pathways of 
carcinogenesis and without treatment these pathways can lead to cancer. Figure 2 also shows the 
application of antiapoptotic and antiangiogenic compounds such as Farnesyltransferase inhibitors 
(to inhibit oncogene Ras activity), Retinoids (to stop the abnormal expression of tumor 
suppressor gene Rb), EGF, VGEF and COX-2 growth factor inhibitors to halt the formation of 
new blood vessels. 
 
Figure 2. How cancer chemoprevention works. 
Cancer chemoprevention is of importance to the field of cancer therapy and treatment 
because application of compounds found within nature and those that are similar in structure to 
natural products would be an appropriate alternative to conventional medicine used today for the 
treatment of cancer. Coumarin derivatives have been widely utilized in the synthesis of cancer 
chemoprevenetive agents (Subhas Bose, Rudradas, & Hari Babu, 2002). Some studies suggest 
that naturally occurring coumarins that are taken by mouth have the possibility to induce phase I 
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and II enzymes within the body (Kleiner et al., 2001). These coumarins can also induce GST 
(glutathione s-transferase) activity, a phase II enzyme. It was found that linear furanocoumarins 
when administered showed a lack in the inhibition of pentoxyresorufin ortho-dealkylase (PROD) 
activity in the liver of lab mice. However, isopimpinellin, a chemical isolated from linear 
furanocoumarins increased GST activity in the forestomach and the small intestine of the lab 
mice (Kleiner et al., 2001). Results from this study also suggested that isopimpinellin, induced 
phase I and II enzymes in several tissues within the body and some that are specific for 
polycyclic aromatic hydrocarbons (PAH) carcinogenesis  (Kleiner et al., 2001). Thus coumarins 
are of significance in cancer chemoprevention and phase I and II enzyme induction.            
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CHAPTER 2 
Literature Review 
2.1 Naturally Occurring Coumarins  
 
Figure 3. Structures of some naturally occurring coumarins. 
2.1.1 Coumarins in foods. Coumarin, an oxygen heterocycle, has been found naturally 
in fruits and vegetables that we eat (Singh, Devi, Thokchom, & Sharma, 2010). Figure 3 shows 
the structures of some of the numerous coumarin derivatives that are found naturally. Coumarin, 
chemical name 1,2-benzopyrone are consumed by humans on a regular basis. In celery, the pulp 
and rind of limes is where furanocoumarin isopimpinellin is found. The coumarin derivative is 
found in fruits such as strawberries, grapefruits, apricots and cherries also. Cumin (used to make 
curry powder), cinnamon, parsnips, are used as flavorings in food preparation, are some of the 
numerous plant based foods that naturally contain coumarins (Kleiner et al., 2001). Coriander, 
cilantro in its leaf form, contains coumarin derivative 7-methylcoumarin.  
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2.1.2 Coumarins in plants. Coumarins are also found naturally in plants as well. The 
plant sweet clover has a high content of coumarin which is responsible for the sweet aroma of 
the plant. Lavender, Tonka beans, and Licorice  are other plants with high coumarin content as 
well (Goel, Prasad, Parmar, Ghosh, & Saini, 2007). Herniaria glabra, common name rupturewort, 
which is believed to have diuretic properties, contains the coumarin derivative 7-
methoxycoumarin (Santamour Jr & Riedel, 1994). Not only are coumarins founds naturally in 
plants and foods, they possess medicinal properties as well. Some derivatives contain anti-
oxidant, diuretic, anti-bacterial, and anti-hypertensive properties, while others have anti-HIV, 
and anti-tumor properties (Goel et al., 2007). From these foods naturally containing coumarins, 
they can be eaten to possibly reduce or minimize one’s development of cancer.   
2.1.3 Coumarins for medicinal use. From the molding of the sweet clover plant by 
fungi such as penicillium, the coumarin derivative dicoumarol is formed (Kresge, Simoni, & 
Hill, 2005). In the 1920s, when cattle would eat the molded sweet clover, it caused them to bleed 
excessively due to dicoumarol’s anti-coagulant properties (Antonella Tonna, 2004). In the 1940s, 
dicoumarol was used as an anti-coagulant drug to treat individuals with thrombosis which is the 
formation of blood clots in blood vessels that could potentially migrate to other parts of the body 
(Antonella Tonna, 2004). In 1954 dicoumarol was officially discontinued, as Warfarin (another 
coumarin derivative) was approved for use as an anti-coagulant drug which is currently still 
administered to treat thrombosis.  
2.2 Synthesis of Coumarin Derivatives  
 As stated previously, coumarin derivatives have been widely utilized in the synthesis of 
cancer chemopreventive agents (Subhas Bose et al., 2002).There are numerous routes to 
synthesize the coumarin derivative. Scheme 1 illustrates a few synthetic routes to obtain the 
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coumarin derivative. Each reaction listed undergoes condensation. The Witting reaction is shown 
in reaction 1. The reaction takes place via a one pot synthesis of ethyl bromoacetate and ortho-
hydroxybenzaldehyde in the presence of triphenylphosphine. Triethylamine is used as the base in 
this synthesis. The reaction labeled 2 is the Knoevenagel condensation of salicylaldehyde with 
various derivatives of ethyl acetoacetate under microwave irradiation. 
 
 
Scheme 1. Various synthetic routes to obtain coumarin derivatives. 
In reaction 1, piperdine is utilized as the base. How the reaction proceeds is deprotonation 
from the piperdine allows for enol formation. The enol that is formed reacts with the aldehyde to 
have elimination of the aldol to obtain the coumarin molecule (Bogdal, 1998). In 1883, chemists, 
Hans Von Pechmann and Duisberg in were the first to synthesize 7-hydroxy-4-methylcoumarin 
12 
 
(β-methylumbelliferone) via condensation of the phenol and β- keto ester, resorcinol and ethyl 
acetoacetate. The Von Pechmann condensation can occur via numerous synthetic routes. The 
standard method for synthesizing coumarins via the Von Pechmann route is the reaction of 
phenol with ethyl acetoacetate in sulfuric acid. The overall mechanism is carried out under acidic 
conditions. Reaction scheme 3, in scheme 1 shows the reaction takes place via the condensation 
of Malic acid in the presence of sulfuric acid at 120
o
C. Formylacetic acid is formed in situ (in 
solution). The formylacetic acid reacts with the resorcinol to yield the coumarin derivative.     
 
Scheme 2. General synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione. 
The studies of others have shown that the synthesis of 4-methyl coumarins via the Von 
Pechmann reaction proves to be a simple and capable way of carrying out the synthesis. A study 
conducted by D. Bose, A. Rudradas and M. Babu utilized Indium (III) chloride as a catalyst for 
the Von Pechmann condensation under solvent free conditions. They obtained excellent results 
with coumarin derivatives in high percent yields (90% yields or more in most cases) thus proving 
Indium Chloride’s effectiveness in catalyzing the reaction (Subhas Bose et al., 2002). From their 
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studies and the excellent results they obtained, the Von Pechmann condensation utilizing Indium 
Chloride was chosen as the synthetic route to obtain the coumarin derivatives for this research.  
 Scheme 2 illustrates the synthetic steps taken to obtain the target molecules that are 7-
hydroxy-4-methyl substituted 2H-chromene-2-thiones. These will be the necessary steps taken to 
obtain the target molecule within this research. For this particular study, ethyl acetoacetate was 
the β-keto ester of choice. Indium (III) chloride was used as a catalyst in this reaction due to its 
proven effectiveness as a Lewis acid catalyst. In this study, eight compounds were synthesized 
using various phenols and a β-keto ester. 
2.3 Synthesis of 2H-Chromene-2-Thiones  
 
Figure 4. Structure of Lawesson’s reagent. 
2.3.1 Lawesson’s reagent. Figure 4 shows the chemical structure of Lawesson’s 
Reagent. Lawesson’s Reagent is a potent yet mild thionating agent that has been widely utilized 
as it successfully transforms an oxygen atom into its respective thio analog (Z. Wang, 2010). It 
has also been used to carry out the transformation of carbon-oxygen single bonds into carbon-
sulfur single bonds. Lawesson’s Reagent has also been used for the cyclization of compounds 
that obtain at the least two oxygen atoms (Z. Wang, 2010). For this particular research 7-
hydroxy-4-methyl derivatives are obtained for each synthesis due to ethyl acetoacetate being the 
β-keto ester of choice for the synthesis of the coumarins, and when converted into the 2H-
chromene-2-thione derivative only the oxygen atom will be replaced. Preliminary studies suggest 
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that using Lawesson’s reagent to carry out the conversion of 7-hydroxy-4-methyl coumarin to 7-
hydroxy-4-methyl 2H-chromene-2-thione, is an easy and effective way of doing so (shown in 
scheme 1). This is due to the Lawesson’s reagent’s ability to easily substitute the oxygen atom 
for a sulfur atom (Levai & Jekoe, 2005).  
 
Scheme 3. General synthesis of 2H-chromene-2-thione. 
Table 1 
Different Classes of Cancer Chemopreventive Agents 
Blocking Agents Suppressing Agents 
Anti-oxidants 
 
Anti-inflammatory 
Free Radical 
 Scavengers 
 
 
Protease inhibitors 
Inducers of Glutathione S-
transferase 
 
 
Protein Kinases 
Modifiers of mixed function 
oxidases 
Ornithine Decarboxylase 
 Inhibitors of prostaglandin synthesis 
2.4 Michael Acceptors 
Cancer chemopreventive agents are classified by the mechanism in which they inhibit 
carcinogenesis. According to studies conducted by Arnold and Wilkinson et.al, indicates there 
are three distinct categories that majority of cancer chemopreventives fall within; those are, 
agents that block the reactive metabolites from the target sites of cells, agents that suppress 
progression or promotion of neoplasia, and those that prevent metabolic activation of the 
carcinogen (Arnold, Wilkinson, Sharma, & Steele, 1995). There are nine classes of 
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chemopreventive agents; table 1 lists the nine classes. As seen in the table, some of these agents 
within this class are anti-oxidants, free radical scavengers, inducers of glutathione S-transferase, 
and anti-inflammatory. Some of the agents could aid in the inhibition of the binding and 
metabolism of carcinogens during the initiation phase, while others suppress the promotion 
phase of carcinogenesis.  
 
Scheme 4. Michael adduct formation. 
Michael acceptors are cancer chemopreventive agents that stop the progression of 
carcinogenesis. The mechanism the Michael acceptors begin with a formation of a covalent 
adduct of the Michael donor to the Michael acceptor (Dorai & Aggarwal, 2004). Scheme 4 
illustrates the formation of the covalent Michael adduct.  Biologically native Michael donors are 
compounds that are found within the body such as glutathione S-tranferase. We envisage that a 
nontoxic xenobiotic such as coumarin derivatives (Michael acceptors) can be introduced into the 
body and will begin a cascade of detoxification processes.   
Coumarins are well known cancer chemopreventive agents and acts as an excellent 
Michael acceptor as it has proven capabilities of suppressing the progression of neoplasia in 
human lung adenocarcinoma cells (Goel et al., 2007). This occurs by allowing for the cells to 
undergo apoptosis. Figure 3 shows the structure of coumarin and its respective thio analog. As 
seen, the structures of the molecules are similar. The only variance is the oxygen atom is 
substituted for a sulfur atom. To improve the 1,4-addition, a sulfur atom is substituted at the 2 
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position of the coumarin due to the softness of sulfur. Softness in organic chemistry refers to an 
atom that has a small oxidation state (charge on the atom) and is strongly polar meaning its 
ability to share electrons with other atoms is high. Oxygen is a hard atom which means that it is 
smaller than sulfur and in conjunction with being very electronegative these factors are 
responsible for its hardness. Sulfur is twice the size of oxygen and very polar which allows 
Sulfur to share its electrons with other atoms. By making the substitution, the Michael acceptor 
is believed to be better at inhibiting carcinogenesis. Studies by chemists, Kumar and Singh et.al, 
proves that 2H-chromene-2-thione derivatives have better cancer chemopreventive activity than 
its analogous coumarin derivative. The 2H-chromene-2-thione derivatives studied showed free 
radical scavenging and anti-inflammatory properties.   
 
Figure 5. Structure of 2H-chromene-2-one and thione. 
2.5 2H-Chromene-2-Thione Derivatives as Chemopreventive Agents   
 Few studies have been conducted on 2H-chromene-2-thione derivatives and their ability 
to act as cancer chemopreventive agents. However, via the research of Sharma, 2H-chromene-2-
thione have proven to obtain excellent capabilities in being utilized as cancer chemopreventive 
compounds due to their potency (Kumar et al., 2005). 2H-chromene-2-thione derivatives and 
their ability to inhibit TNF-α induced ICAM-1 expression on human umbilical vein endothelial 
cells have been studied (Kumar et al., 2005). TNF-α is tumor necrosis factor a signaling protein 
that is responsible for inflammatory response in humans. This is why individuals with chronic 
disorders such as asthma, and rheumatoid arthritis experience episodes of inflammation. TNF-α 
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is responsible for the expression of Inter Cellular Adhesion Molecule-1 (ICAM-1) which is a 
protein expressed by human genes that are typically found in endothelial cells. ICAMs are 
molecules that are responsible for cell to cell binding to allow for transmigration of the 
leukocytes into the endothelial cells that are located within blood vessels. With the 
overexpression of ICAM-1, this can allow for infiltration of leukocytes across the blood vessels 
and allow for inflammation to occur. S. Kumar, and B. Singh during their study, concluded that 
7,8-dibenzyloxy-4-methyl-2H-chromene-2-thione was superior over the 7,8-dibenzyloxy-4-
methylcoumarin in the inhibition of TNF-α induced ICAM-1 expression (Kumar et al., 2005). 
The structure of the two chemical compounds may be an explanation as to why the 2H-
chromene-2-thione worked better than the coumarin (Kumar et al., 2005).    
Sulfur is of significance in this research because sulfur is one of the components in 
numerous organic compounds that have biological functions within the body. The compounds 
that were synthesized in this research will potentially induce enzymes found within the body. 
The thio group is a very important component in regards to biological functions. For example, 
glutathione, a peptide which contains a sulfur group, is involved in protein and DNA synthesis. 
Environmental and drug toxin metabolism and amino acid transports are some of the many 
functions of glutathione as well (Trudy McKee, 2011). Glutathione can also be used as a 
reducing agent by protection of cells from the vicious effects of oxidation. How this occurs is  
glutathione reacts with peroxides which are bi-products of O2 metabolism (Trudy McKee, 2011). 
An example of this is, in red blood cells, hydrogen peroxide (H2O2) oxidizes the iron in 
hemoglobin to its ferric form Fe
+3
. From this reaction a product methemoglobin, is produced. 
However, methemoglobin cannot attach itself to oxygen, therefore glutathione acts as a reducing 
agent by reducing hydrogen peroxide to protect against the formation of methemoglobin (Trudy 
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McKee, 2011). Biological important peptides, glutathione, oxytocin, cysteine, and vasopressin 
all have intra cellular antioxidant activity, and adulteration of these biothiols can be possible 
warning sign of AIDS and various cancers (Kim, Lee, Kwon, & Kim, 2011); hence, the synthesis 
of 2H-chromene-2-thione derivatives and determining their potency (their ability to aid the body 
in retarding the growth of cancer cells) is of great importance (Maresca et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
CHAPTER 3 
Methodology  
3.1 Experimental 
3.1.1 Materials and methods. For this research, Indium (III) chloride, Lawesson’s 
Reagent, Zirconium (IV) Chloride and various Resorcinol derivatives where purchased from 
Acros Chemicals. Ethyl acetoacetate was purchased from Sigma-Aldrich. DMSO ampoules 
(0.75mL) were purchased from Cambridge Isotope Lab Incorporated and the Ethanol used for 
recrystallization was purchased from Fisher. All reagents and solvents were used as purchased. 
3.1.2 Characterization of compounds. For characterization purposes, 
1
H and 
13
C  
Nuclear Magnetic Resonance analysis were obtained using a 300 MHz NMR instrument from 
Varian and 400 MHz instrument from Varian used at the North Carolina Agricultural and 
Technical State University Joint School of Nanoscience and Nanoengineering. Preparation of the 
coumarin samples for NMR analysis was carried out using ampoules of Dimethyl Sulfoxide 
(0.75mL) to dissolve the coumarin. Each sample was dissolved with the DMSO and placed into 
sample tubes for NMR analysis. 
1
H and 
13
C NMR chemical shifts for the coumarin and 2H-
chromene-2-thione are expected to vary in the 
1
H and 
13
C NMR. This variation will determine if 
the coumarin was converted into its thio analog.  
 
Scheme 5. Synthesis of 7-hydroxy-4-methylcoumarin.  
3.2 Synthesis of Coumarin Derivatives  
3.2.1 Synthesis of 7-hydroxy-4-methylcoumarin (3). As shown in scheme 4, the 
synthesis of 7-hydroxy-4-methylcoumarin took place via a mixture of 1.103g of Resorcinol (1.0 
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mmol) and 1.304g of ethyl acetoacetate (1mmol) that refluxed for 1hr. in the presence of Indium 
Chloride as the catalyst. After the reflux, the reaction mixture was cooled to room temperature, 
and then washed with cold deionized water. After the water wash, the reaction mixture was 
filtered and re-crystallized with hot EtOH. After recrystallization, the product was filtered and 
washed with EtOH. In the final step, the product was placed into a storage vial and onto the high 
vacuum line for further drying overnight. Beige powder; 80% yield; m.p. 184
o
C (Sharma, 
Janardhan Reddy, Sree Lakshmi, & Radha Krishna, 2005) 
1
H NMR (301 MHz, DMSO-d6) δ 
10.53 (s, 1H), 7.58 (d, J = 8.7 Hz, 1H), 6.79 (d, J = 11.0 Hz, 1H), 6.69 (s, 1H), 6.12 (s, 1H), 2.35 
(d, J = 1.0 Hz, 3H). 
3.2.2 Synthesis of 7-hydroxy-4,8-dimethylcoumarin (4). The synthesis of 7-hydroxy-
4,8 dimethylcoumarin took place via a mixture of 1.24g of Resorcinol (1.0 mmol) and 1.304g of 
Ethyl Aceto Acetate (1.0 mmol) that refluxed for 1hr. white powder; 84% yield; m.p. 253-255
o
C 
(Sharma et al., 2005) 
1
H NMR (301 MHz, DMSO-d6) δ 10.41 (s, 1H), 7.54 – 7.36 (m, 2H), 6.86 
(d, J = 9.4 Hz, 2H), 6.12 (s, 2H), 2.36 (s, 3H), 2.15 (s, 3H). 
13
C NMR (101 MHz, cd3cn) δ 
197.56, 163.24, 157.82, 146.33, 126.05, 115.20, 113.72, 100.36, 55.88, 29.90, 17.18. 
3.2.3 Synthesis of 6-chloro-7-hydroxy-4-methylcoumarin (5). The synthesis of 6-
chloro-7-hydroxy-4-methylcoumarin took place via a mixture of 1.45g of 4-Chloro Resorcinol 
(1.0 mmol) and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. Brown powder; 
8% yield; m.p. 278
o
-280
o
C (Chakravarti & Ghosh, 1935) 
1
H NMR (301 MHz, DMSO-d6) δ 
11.40 (s, 1H), 7.75 (s, 1H), 6.88 (s, 1H), 6.20 (s, 1H), 2.37 (s, 3H).  
3.2.4 Synthesis of 6-n-dodecyl-7-hydroxy-4-methylcoumarin (6). The synthesis of 7-
hydroxy-4-methylcoumarin took place via a mixture of 2.784g of 4-n-dodecyl Resorcinol (1.0 
mmol) and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. Tan crystals; 84.8% 
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yield; m.p. 138
o
C (Kansara & Shah, 1948);  
1
H NMR (301 MHz, DMSO-d6) δ 10.46 (s, 1H), 
7.40 (s, 1H), 6.70 (s, 1H), 6.08 (d, J = 1.3 Hz, 1H), 2.34 (d, J = 1.2 Hz, 3H), 1.51 (p, J = 6.6 Hz, 
2H), 1.22 (d, J = 12.1 Hz, 15H), 0.82 (t, J = 6.4 Hz, 3H). 
3.2.5 Synthesis of 7,8-dihydroxy-4-methylcoumarin (7). The synthesis of 7,8-
dihydroxy 4-methylcoumarin took place via a mixture of 1.261g of Pyrogallol (1.0 mmol) and 
1.304g of ethyl acetoacetate (1.0 mmol)  that refluxed for 1hr. purple crystals; 46.4% yield; m.p. 
241-243
o
C (Sharma et al., 2005) 
1
H NMR (301 MHz, DMSO-d6) δ 7.70 (s, 1H), 7.68 (s, 1H), 
6.97 (d, J = 8.5 Hz, 1H), 6.95 (s, 1H), 6.21 (s, 1H), 3.86 (s, 5H), 2.40 (s, 3H). 
3.2.6 Synthesis of 7-methoxy-4-methylcoumarin (8). The synthesis of 7-methoxy-4-
methylcoumarin took place via a mixture of 1.241g of 3-methoxy phenol (1.0 mmol) and 1.304g 
of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. white powder; 33.3% yield; m.p. 159-
160
o
C (Shirini, Zolfigol, & Albadi, 2010);  
1
H NMR (301 MHz, DMSO-d6) δ 10.04 (s, 1H), 9.28 
(s, 1H), 7.09 (d, J = 8.7 Hz, 1H), 6.81 (d, J = 8.6 Hz, 1H), 6.12 (s, 1H), 2.35 (s, 3H). 
3.2.7 Synthesis of 5,7-dihydroxy-4-methylcoumarin (9). The synthesis of 5,7-
dihydroxy 4-methylcoumarin took place via a mixture of 1.261g of Phloroglucinol (1.0 mmol) 
and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. Orange powder; 66% yield; 
m.p. 280-281
o
C (Sharma et al., 2005);  
1
H NMR (301 MHz, DMSO-d6) 
1
H NMR (301 MHz, 
DMSO-d6) δ 10.52 (s, 1H), 10.29 (s, 1H), 6.25 (d, J = 2.3 Hz, 1H), 6.16 (d, J = 2.3 Hz, 1H), 5.84 
(d, J = 1.2 Hz, 1H), 2.48 (s, 3H). 
3.2.8 Synthesis of 5-hydroxy-4,7-dimethylcoumarin (10). As shown in scheme 10, the 
synthesis of 5-hydroxy-4,7-dimethylcoumarin took place via a mixture of 1.065g of orcinol (1.0 
mmol) and 1.116g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr. white powder; 76% 
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yield m.p. 259-260
o
C (Y. Wang, Xu, Tian, Li, & Wang, 2009) 
1
H NMR (301 MHz, DMSO-d6) δ 
6.62 (s, 1H), 6.57 (s, 1H), 6.05 (s, 1H), 2.54 (s, 3H), 2.27 (s, 3H). 
3.2.9 Synthesis of 7-methoxy-4-methylcoumarin (11). As shown in scheme 11, the 
synthesis of 7-methoxy-4-methylcoumarin took place via a mixture of 1.241g of 3-methoxy 
phenol (1.0 mmol) and 1.304g of ethyl acetoacetate (1.0 mmol) that refluxed for 1hr.Ivory 
powder; 40% yield; m.p. 159-160
o
C (Shirini et al., 2010) 
1
H NMR (301 MHz, DMSO-d6) δ 6.98 
(s, 1H), 6.20 (s, 1H), 3.85 (s, 3H), 2.39 (d, J = 1.3 Hz, 3H). 
3.3 Synthesis of Coumarin Derivatives with ZrCl4 
 
 
Scheme 6. Synthesis of 7,8-dihydroxy-4-methylcoumarin. 
3.3.1 Synthesis of 7,8-dihydroxy-4-methylcoumarin (12). Into a 50mL round bottom 
flask 1.26g of pyrogallol, 1.30g of ethyl acetoacetate was allowed to react in the presence of 
0.233g of ZrCl4. The reaction took place at room temperature and stirred for 10 minutes. After 
10 minutes, the reaction mixture was quenched with cold DI water, washed (3x with cold DI 
water) and filtered via vacuum filtration. After the filtration, the product was placed into a 
storage vial, and placed onto the hot vacuum for drying overnight. Purple powder ; 21% yield; 
m.p. 241-243
o
C (Sharma et al., 2005) 
1
H NMR (301 MHz, Methanol-d4) δ 4.82 – 0.93 (m, 1H). 
3.3.2 Synthesis of 7-hydroxy-4-methylcoumarin (13). (1.10g) of Resorcinol, (1.30g) 
ethyl acetoacetate, (0.145g) ZrCl4. White powder  ; 35% yield. m.p. 184
o
C (Sharma et al., 2005)  
1
H NMR (400 MHz, DMSO-d6) δ 9.56 (s, 1H), 7.05 (d, J = 8.5 Hz, 1H), 6.46 (d, J = 2.5 Hz, 1H), 
6.20 (s, 1H), 1.64 (s, 3H). 
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3.3.3 Synthesis of 5-hydroxy-4,7-dimethylcoumarin (14). (1.24g) of Orcinol, (1.30g) 
ethyl acetoacetate, (0.232g) ZrCl4. 13% yield; m.p.259-260
o
C (Sharma et al., 2005); 
1
H NMR 
(301 MHz, DMSO-d6) δ 10.54 (s, 1H), 6.62 (s, 1H), 6.56 (s, 1H), 6.06 (s, 1H), 2.28 (s, 3H), 2.09 
(s, 3H). 
3.3.4 Synthesis of 6-chloro-7-hydroxy-4-methylcoumarin (15). (2.89g) of 4-chloro 
resorcinol, (2.60g) ethyl acetoacetate, (0.931g) ZrCl4. Beige solid; 11% yield; m.p. 278-280
o
C 
(Chakravarti & Ghosh, 1935) 
1
H NMR (301 MHz, Pyridine-d5) δ 9.03 (s, 1H), 7.96 (d, J = 42.4 
Hz, 1H), 7.52 (s, 1H), 6.49 (s, 1H). 
3.3.5 Synthesis of 7-hydroxy-4-methylcoumarin (16). (1.10g) of Resorcinol, (1.30g) 
ethyl acetoacetate, (0.145g) ZrCl4. Purple crystals; 68% yield; m.p. 184
o
C (Sharma et al., 2005); 
1
H NMR (301 MHz, DMSO-d6) δ 10.52 (s, 1H), 7.65 – 7.53 (m, 1H), 6.70 (t, J = 1.8 Hz, 1H), 
6.11 (d, J = 1.8 Hz, 1H), 2.43 – 2.28 (m, 3H). 
3.4 Synthesis of TBDMS Coumarin Derivatives 
 
Scheme 7. Synthesis of 7-TBDMS-4,8-dimethylcoumarin. 
3.4.1 Synthesis of 7-tbdms-4,8-dimethylcoumarin (17). A solution of 7-hydroxy-4,8-
dimethylcoumarin (0.5g, 1.0eq) was treated with TBDMSCl (1.1eq) and Et3N (1.0eq) in THF 
(20mL).The reaction was stirred at room temperature until the starting material was no longer in 
solution (~18hrs). The reaction was monitored via TLC to determine if the reaction was 
complete. The reaction was quenched with H2O (40mL) and extracted with ethyl acetate (3x 
15mL). The organic layers were combined and washed with H2O (2x 20mL), and dried with 
O O
CH3
O
Si
CH3
O O
CH3
CH3
HO
Si
Cl
THF
N
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Na2SO4. The product was filtered and concentrated under vacuum to give a residue that was 
purified by silica gel column chromatography eluting with 20% ethyl acetate/n-hexane (v/v). 
white powder; 68% yield;  
1
H NMR (301 MHz, DMSO-d6) δ 10.47 (dd, J = 15.8, 9.1 Hz, 3H), 
7.62 – 7.42 (m, 3H), 6.90 (q, J = 8.6, 7.5 Hz, 3H), 6.29 – 6.09 (m, 3H), 5.44 – 5.23 (m, 2H), 3.61 
– 3.41 (m, 7H), 3.02 (s, 1H), 2.96 – 2.76 (m, 1H), 2.62 (s, 3H), 2.45 – 2.34 (m, 8H), 2.31 – 2.12 
(m, 9H), 1.11 – 0.81 (m, 29H), 0.21 – 0.04 (m, 2H). 
3.4.2 Synthesis of 5,7-(tbdms)2-4-methylcoumarin (18). 5,7-dihydroxy-4-
methylcoumarin 0.808g, (1.0eq) was treated with 0.696g TBDMSCl (1.1eq) and 0.425g Et3N 
(1.0eq) in THF (20mL).The reaction was stirred at room temperature until the starting material 
was no longer in solution (~18hrs). Ivory powder; 21% yield 
1
H NMR (301 MHz, DMSO-d6) δ 
6.23 (s, 1H), 6.14 (s, 1H), 5.83 (s, 1H), 1.21 (s, 2H). 
3.4.3 Synthesis of 5-tbdms-4,7-dimethylcoumarin (19). 5-hydroxy-4,7-
dimethylcoumarin 0.752g, (1.0eq) was treated with TBDMSCl 0.447g (1.1eq) and 0.274g Et3N 
(1.0eq) in THF (20mL).The reaction was stirred at room temperature until the starting material 
was no longer in solution (~18hrs). 0.31% yield; 
1
H NMR (301 MHz, Acetonitrile-d3) δ 6.67 (s, 
1H), 6.56 (s, 1H), 5.98 (d, J = 1.5 Hz, 1H), 2.56 (d, J = 6.4 Hz, 3H), 2.32 (d, J = 6.0 Hz, 3H), 
1.00 (d, J = 1.4 Hz, 2H), 0.36 (s, 1H).  
3.4.4 Synthesis of 6-n-dodecyl-7-tbdms-4-methylcoumarin (20). 6-n-dodecyl- 7-
hydroxy-4-methylcoumarin 2.0g, (1.0eq) was treated with 0.965g TBDMSCl (1.1eq) and 0.370g 
Et3N (1.0eq) in THF (25mL).The reaction was stirred at room temperature until the starting 
material was no longer in solution (~18hrs). Tan solid; 47% yield; 
1
H NMR (301 MHz, DMSO-
d6) δ 7.41 (s, 1H), 6.74 (d, J = 13.2 Hz, 1H), 6.09 (s, 1H), 2.37 (d, J = 7.9 Hz, 3H), 1.53 (s, 3H), 
1.25 (d, J = 13.5 Hz, 19H), 0.99 (s, 2H), 0.94 – 0.71 (m, 5H), 0.28 (s, 1H), -0.05 (s, 1H). 
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3.4.5 Synthesis of 7,8-(tbdms)2-4-methylcoumarin (21). 7,8-dihydroxy-4-
methylcoumarin 1.980g (1.0eq) was treated with TBDMSCl (1.1eq) and 1.016g Et3N (1.0eq) in 
THF (20mL).The reaction was stirred at room temperature until the starting material was no 
longer in solution (~18hrs). White powder; 15% yield; 
1
H NMR (301 MHz, DMSO-d6) δ 6.91 (d, 
J = 8.5 Hz, 1H), 6.63 (d, J = 8.4 Hz, 1H), 5.95 (s, 2H), 2.33 (s, 3H), 2.18 (s, 6H), 0.84 (s, 6H). 
3.5 Synthesis of 2H-Chromene-2-Thione Derivatives 
 
Scheme 8. Synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione. 
3.5.1 Synthesis of 7-hydroxy-4-methyl-2h-chromene-2-thione (3a). As shown in 
scheme 12, the synthesis of 7-hydroxy-4-methyl-2H-chromene-2-thione will take place via a 
mixture of 7-methoxy-4-methylcoumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) 
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. After the 
reflux, the reaction mixture was evaporated under reduced pressure to collect the product. The 
solid product was re-crystallized from methanol to give 7-hydroxy-4-methyl-2H-chromene-2-
thione. Brown solid crystals. 11% yield. 
1
H NMR (400 MHz, DMSO-d6) δ 10.89 (s, 1H), 7.72 (s, 
1H), 7.06 (s, 1H), 6.93 (s, 1H), 6.88 (s, 1H), 2.35 (s, 3H). IR (KBr): ν 3183, 2366, 1619, 1595, 
1546, 1443, 1397, 1304, 1265, 1215, 1156, 1099, 1070 cm 
-1
 
3.5.2 Synthesis of 7-hydroxy-4,8-dimethyl-2h-chromene-2-thione (4a). The synthesis 
of 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione will take place via a mixture of 7-hydroxy-4,8 
dimethylcoumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) refluxed in ~30mL (less in 
some cases) of hot anhydrous (dry) toluene for 3 hours. Dark green solid; 54% yield; m.p. 205
o
C 
1
H NMR (400 MHz, Acetonitrile-d3) δ 7.67 (dt, J = 8.7, 0.4 Hz, 1H), 7.30 – 6.60 (m, 3H), 3.89 
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(s, 3H), 2.33 (d, J = 1.1 Hz, 4H). 
13
C NMR (101 MHz, cd3cn) δ 197.56, 163.24, 157.82, 146.33, 
126.05, 115.20, 113.72, 100.36, 55.88, 29.90, 17.18. IR (KBr): ν 1632, 1599, 1546, 1513, 1447, 
1387, 1298, 1245, 1208, 1149, 1096 cm
-1
  
3.5.3 Synthesis of 7-tbdms-4,8-dimethyl-2h-chromene-2-thione (4b). The synthesis of 
Synthesis of 7-tertbutyldimethylsilyloxy-4,8-dimethyl-2H-chromene-2-Thione will take place 
via a mixture of 7-tertbutyldimethylsilyloxy-4,8-dimethylcoumarin (5.0 mmol) and Lawesson’s 
Reagent (6.0 mmol) refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 
hours. Yellow powder; 33% yield; m.p. 243
o
C; 
1
H NMR (301 MHz, DMSO-d6) δ 7.59 (dd, J = 
13.8, 6.6 Hz, 1H), 7.21 (d, J = 21.9 Hz, 1H), 6.99 (s, 1H), 2.43 – 2.02 (m, 3H), 0.85 (d, J = 6.7 
Hz, 1H), 0.13 (s, 1H), -0.05 (s, 1H). IR (KBr): ν 1615, 1595, 1556, 1500, 1443, 1387, 1278, 
1156, 1106, 1020, 755 cm 
-1 
3.5.4 Synthesis of 6-chloro-7-hydroxy-4-methyl-2h-chromene-2-thione (5a). The 
synthesis of 6-chloro-7-hydroxy-4-methyl-2H-chromene-2-thione will take place via a mixture 
of 6-chloro-7-hydroxy-4-methylcoumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) 
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. An azeotrope 
was done using ethanol to remove the solvent from the reaction mixture. Brown powder. 46% 
yield. m.p. 243
o
C; 
1
H NMR (400 MHz, Acetonitrile-d3) δ 7.67 (s, 1H), 7.00 (s, 1H), 6.56 (s, 0H), 
5.01 (s, 3H). 
13
C NMR (101 MHz, CD3CN) δ 197.02, 157.76, 155.88, 144.23, 127.12, 113.81, 
112.07, 108.66, 55.12, 22.38.  
3.5.5 Synthesis of 6-n-dodecyl-7-hydroxy-4-methyl-2h-chromene-2-thione (6a). As 
shown in scheme 14, the synthesis of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione 
will take place via a mixture of 6-n-dodecyl-7-hydroxy-4-methylcoumarin (5.0 mmol) and 
Lawesson’s reagent (6.0 mmol) refluxed in ~30mL (less in some cases) of hot anhydrous (dry) 
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toluene for 3 hours. Yellow powder 31% yield; m.p. 299
o
C; 
1
H NMR (400 MHz, Chloroform-d) 
δ 7.55 (s, 1H), 7.03 (t, J = 1.1 Hz, 1H), 6.90 (s, 1H), 2.63 – 2.56 (m, 2H), 2.36 (d, J = 1.1 Hz, 
3H), 1.34 – 1.18 (m, 16H), 0.90 – 0.81 (m, 3H). 13C NMR (101 MHz, cdcl3) δ 197.25, 158.62, 
156.35, 128.92, 125.99, 125.27, 115.01, 111.69, 102.54, 31.90, 30.93, 29.99, 29.65, 29.62, 29.59, 
29.48, 29.47, 29.33, 22.67, 18.20, 14.10. IR (KBr): ν 2915, 1625, 1559, 1390, 1265, 1215 cm -1 
3.5.6 Synthesis of 7,8-dihydroxy-4-methyl-2h-chromene-2-thione (7a). As shown in 
scheme 15, the synthesis of 7,8-dihydroxy-4-methyl-2H-chromene-2-thione thiocoumarin will 
take place via a mixture of 7,8-dihydroxy-4-methylcoumarin (5.0 mmol) and Lawesson’s 
Reagent (6.0 mmol) refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 
hours. Yellow solid; 21% yield;  m.p. 230-235
o
C 
1
H NMR (DMSO-d6 + CDCl3, 300 MHz): d 
2.34 (3H, s, CH3), 6.95 (1H, d, J = 8.6Hz, C-6H), 7.02 (1H, s, C-3H), 7.09 (1H, d, J = 8.6 Hz, C-
5H), 8.83 and 8.94 (2H, 2s, 1H each, 2 · OH); 
13
C NMR (DMSOd6+ CDCl3, 75.5 MHz): d 20.68 
(CH3), 116.42 (C-6), 117.72 (C-10), 118.07 (C-5), 118.31 (C-3), 134.23 (C-4), 148.55 and 
148.93 (C-7 and C-8), 151.96 (C-9) and 199.31 (C-2). IR (KBr): 3312 (OH), 2925, 2855, 1561, 
1434, 1366, 1254 and 1095 cm
-1
 (Kumar et al., 2005)
 
3.5.7 Synthesis of 7-methoxy-4-methyl-2h-chromene-2-thione (8a). As shown in 
scheme 16, the synthesis of 7-methoxy-4-methyl-2H-chromene-2-thione will take place via a 
mixture of 7-methoxy-4-methyl coumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) 
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours. An azeotrope 
was done using hexanes to extract the product from the reaction mixture. Brown crystals; 61% 
yield; m.p. 183
o
C; 
1
H NMR (400 MHz, Acetonitrile-d3) δ 7.74 – 7.63 (m, 1H), 7.04 (q, J = 1.1 
Hz, 1H), 7.02 (d, J = 0.4 Hz, 0H), 7.01 (d, J = 2.5 Hz, 0H), 6.99 (d, J = 2.5 Hz, 0H), 3.90 (s, 3H), 
2.34 (d, J = 1.1 Hz, 3H), 2.09 (s, 3H).
 13
C NMR (101 MHz, cd3cn) δ 202.17, 197.60, 163.26, 
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157.85, 146.36, 126.28, 115.22, 113.73, 100.38, 55.89, 17.17. IR (KBr): ν 1625, 1599, 1546, 
1443, 1387, 1294, 1245, 1208, 1146, 1070, 841 cm
-1
 
3.5.8 Synthesis of 5,7-dihydroxy-4-methyl-2h-chromene-2-thione (9a). As seen in 
scheme 17, the synthesis of 5,7-dihydroxy-4-methyl-2H-chromene-2-thione will take place via a 
mixture of 5,7-dihydroxy-4-methyl coumarin (5.0 mmol) and Lawesson’s reagent (6.0 mmol) 
refluxed in ~30mL (less in some cases) of hot anhydrous (dry) toluene for 3 hours.  
1
H NMR 
(400 MHz, Acetonitrile-d3) δ 7.84 – 7.61 (m, 1H), 7.10 – 6.94 (m, 1H), 5.63 (s, 1H). 
13
C NMR 
(101 MHz, cd3cn) δ 206.66, 162.71, 160.37, 157.24, 156.91, 133.08, 132.42, 113.65, 109.85, 
23.00.  
3.5.9 Synthesis of 5-hydroxy-4,7-dimethyl-2h-chromene-2-thione (10a). The synthesis 
of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione will take place via a mixture of 6-chloro-7 
hydroxy-4-methyl coumarin (5.0 mmol) and Lawesson’s Reagent (6.0 mmol) refluxed in ~30mL 
(less in some cases) of hot anhydrous (dry) toluene for 3 hours. Brown solid; 13% yield; m.p. 
249-250
o
C; 
1
H NMR (400 MHz, Chloroform-d) δ 7.47 (d, J = 38.5 Hz, 1H), 6.78 (s, 1H), 6.64 
(s, 1H), 6.47 (s, 1H), 2.13 (s, 3H).
 13
C NMR (101 MHz, cdcl3) δ 200.96, 162.49, 161.98, 153.01, 
149.10, 131.62, 113.82, 112.74, 27.94, 26.46. IR (KBr): ν 1625, 1586, 1539, 1506, 1443, 1278, 
1338, 1156, 1132, 828 cm
-1 
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CHAPTER 4 
Results and Discussion 
4.1 Discussion 
To improve the effectiveness of coumarin as a therapeutic compound for the treatment of 
cancer, a sulfur atom was substituted at the 2 position on the coumarin. To increase the potency 
of the compound (meaning to increase the compounds ability to enhance the activity of 
mechanisms already within the body) a sulfur atom was substituted for this reason also. Each 
coumarin and 2H-chromene-2-thione derivatives were synthesized successfully. To determine if 
indeed the coumarin and 2H-chromene-2-thione derivatives were synthesized, the NMR 
instrument was used to characterize each compound synthesized. 
 
Scheme 9. Mechanism of Von Pechmann condensation. 
4.1.1 Mechanism of the von pechmann condensation. The Von Pechmann 
condensation takes place via the condensation of a β-keto ester and a phenol. Derivatives of 
Resorcinol were utilized as the phenol in this research. A strong Brøsted-Lowry Acid or a Lewis 
Acid is required to provide the acidic conditions to carry out the transformation of the coumarin 
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derivatives. Scheme 8 illustrates the mechanism for the coumarin formation. The reaction 
proceeds via the transesterification and keto-enol tautomerisation of the resorcinol and ethyl 
aceto acetate. A Michael 1,4 addition will take place to lay the frame work for the coumarin 
structure. The Michael addition takes place via a conjugate 1, 4 addition of a resonance stabilized 
carbanion (which is the Michael donor) to an activated α,β-unsaturated compound (Michael 
acceptor) (William H. Brown, 2005). The carbon-carbon double bond situated at the four 
position is the Michael acceptor. Rearomatisation follows the Michael addition and a loss of 
water gives the coumarin structure.  
4.1.2 Comparison of lewis acid catalysts. The Von Pechmann condensation utilized in 
this research used green chemistry via a one pot synthesis that required no solvent. No solvent is 
required for the reaction to take place however, ethyl aceto acetate is a liquid reagent which 
creates a homogenous mixture with the catalyst and resorcinol and the reaction can proceed as 
followed. In this particular research, InCl3 was chosen as the Lewis Acid to carry out the 
formation of the coumarin derivatives due to its effectiveness as a catalyst, obtaining the 
coumarin derivatives in 80-90% percent yields. InCl3 although an excellent catalyst for the Von 
Pechmann condensation it is expensive selling at $75 for 10g of the catalyst. ZrCl4, however is 
inexpensive selling at $39 for 10g.  In this research, strategies to efficiently synthesize the 
coumarin derivatives were investigated. To allow for a more green synthesis of the coumarin 
derivatives ZrCl4 was explored as a the Lewis Acid in the Von Pechmann reaction as it has 
proven capability to effectively carry out the transformation of coumarin derivatives in a solvent 
free ten minute reaction at room temperature (Sharma et al., 2005). For this reason, another set of 
coumarin derivatives in the research utilized ZrCl4 as the catalyst. Table 1 displays the coumarin 
derivatives synthesized utilizing InCl3 and ZrCl4 as the catalyst. 
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Table 2 
Percent yields of InCl3 and ZrCl4 Catalyzed procedure 
Compound InCl3 Percent 
Yield (%) 
ZrCl4 Percent Yield 
(%) 
 
 
80 
 
68 
 
 
84 
 
___ 
 
 
13 
 
11 
 
 
85 
 
                         ___ 
 
 
 
46 
 
 
21 
 
 
33 
 
                         ___ 
 
 
66 
 
                         ___ 
 
 
76 
 
13 
Shown in table are the percent yields obtained for the respective coumarin derivatives 
synthesized. The coumarin derivatives synthesized using InCl3 that contain hydroxyl substituents 
all had semi relatively high yields (with the exception of 7,8-dihydroxy-4-methylcoumarin in 
46% percent yield). The 6-chloro-7-hydroxy-4-methylcoumarin resulted in a very low yield; this 
could possibly be due to the solubility of the reagent 4-chloro resorcinol. Table 2 also shows the 
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percent yields of the coumarins obtained via the ZrCl4 procedure. Although the yields were fair, 
from the NMR spectra it proved that several coumarin derivatives were not synthesized, due to 
impurities within the spectra. For the coumarin derivative 7,8-dihydroxy-4-methylcoumarin a 
suitable NMR solvent could not be obtained to perform NMR analysis. Both DMSO and CH2Cl2 
were utilized as the solvent for NMR analysis of the compound but attempts were unsuccessful.  
It was proposed that possibly the hydroxyl groups being adjacent to each other chelated with the 
Zirconium in ZrCl4.   
4.2 Discussion of TBDMS Coumarin Derivatives  
4.2.1 Tertbutyldimethylsilyloxy (tbdms) coumarin derivatives. One method of 
synthesizing the 2H-chromene-2-thione derivatives successfully involved a protection step of the 
hydroxyl substituents attached to the coumarin atom using t-butyldimethylchlorosilane, triethyl 
amine in THF, to minimize the reactivity of the oxygen atoms. The percent yields of the 
protected coumarin derivatives range from 68%-15% respectively. Table 3 shows the 
experimental results obtained from the protection of the hydroxyl substituents on the coumarin 
molecules. The trend shown in the table is the coumarin derivatives that contained multiple 
hydroxyl substituents had lower percent yields than the coumarin derivatives that contained only 
one hydroxyl substituent with the exception of 6-n-dodecyl-7-TBDMS-4-methylcoumarin which 
obtained the highest percent yield (74%). The 12 carbon chain is, therefore steric hindrance is is 
relatively minimized in comparison to branched chain structures. In the 7,8-di-TBDMS-4-
methylcoumarin, the percent yield is lower due to steric hindrance from the branching of both 
substituents that are adjacent to each other. The percent yield of 5-TBDMS-4,7-
dimethylcoumarin was extremely low due insoluble precipitate formation during the work up 
steps to obtain the coumarin derivative. 
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Table 3 
Percent Yields of the Protected Coumarins 
Compounds Percent Yields (%) 
 
 
68 
 
 
 
 
 
 
 
21 
 
 
 
 
 
 
 
 
0.31 
 
 
 
 
 
 
 
74 
 
 
 
15 
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Figure 6. Expected NMR chemical shifts. 
4.3 Expected Coumarin NMR Spectra  
For the 
1
H NMR spectra of the coumarin derivatives a singlet peak around 2.3 ppm is 
expected. This is indicative of methyl protons bound to the allylic carbon on the coumarin 
molecule. This is a key characteristic of the 4 substituted coumarin derivatives synthesized in 
this research. In the aromatic region of the  
1
H NMR spectra two sets of doublets and two singlet 
peaks are expected from the 
1
H NMR spectra. The protons responsible for these chemical shifts 
are the adjacent protons on the aromatic ring (Carbon 5 and 6 in figure 5) and the hydrogen 
attached to the carbon at the eighth position on the aromatic ring (carbon 8 in figure 5). The 
vinylic hydrogen (carbon 3 in figure 5) is responsible for the other singlet peak at 6.1ppm.  Since 
various resorcinol’s were used in the formation of the coumarins also, it is expected that there 
will be hydroxyl peaks in the NMR spectra around 10.0-11.0 ppm.  
4.3.1 Expected thione spectra. With the 2H-chromene-2-thione derivatives, similar 
spectra to the coumarin derivatives is expected for these derivatives as well. However, there will 
be a chemical shift in the protons of the 2H-chromene-2-thione derivatives due to the sulfur atom 
attachment. From the variance in the 
1
H and 
13
C NMR Spectra of coumarin and the 2H-
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chromene-2-thione derivatives, it will be determined if the 2H-chromen-2-thione derivatives 
were synthesized.  
 
Figure 7. 
1
H NMR spectra of 7-hydroxy-4-methylcoumarin. 
4.3.2 Discussion of the 7-hydroxy-4-methylcoumarin spectra. The formation of 
coumarin (3) is shown in scheme 3. This reaction took place via the Von Pechmann condensation 
of equimolar amounts of ethyl aceto acetate and resorcinol. Figure 6 represents the NMR spectra 
obtained from 7-hydroxy 4-methylcoumarin. The coumarin was obtained in 80% yield. From the 
1
H NMR spectra it shows that the desired coumarin was indeed synthesized. In the aromatic 
region, there are two sets of doublet peaks at 6.74ppm and 7.57ppm indicative of the neighboring 
hydrogen’s on the aromatic ring. Also in the aromatic region there is a singlet peak at 6.11δ 
which is the chemical shift for the proton on the aromatic ring at the eighth carbon position 
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(shown in figure 5). The chemical shift at 10.5δ is the hydroxyl proton. The singlet peak at 6.0 is 
the chemical shift of the vinylic proton (the hydrogen attached to the alkene carbon). This proton 
is expected to undergo the most change of all the protons on the coumarin molecule due to the 
proton being adjacent to the sulfur atom in the thione derivatives. 
 
Figure 8. 
1
H NMR spectra of the aromatic region of 7-hydroxy-4-methylcoumarin.  
Also in the aromatic region as shown in figure 8, there is a singlet peak at 6.11δ which is 
the chemical shift for the proton on the aromatic ring at the eighth carbon position (shown in 
figure 5). The chemical shift at 10.5ppm is the hydroxyl proton.  
The singlet peak at 6.0 is the chemical shift of the vinylic proton (the hydrogen attached 
to the alkene carbon). These protons are known to have a shift in this region. It is only when they 
are attached/adjacent to an electronegative atom that they experience a chemical shift. Therefore, 
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the vinylic proton is expected to undergo the most change of all the protons on the coumarin 
molecule due to the proton being adjacent to the sulfur atom in the thione derivatives. 
 
Figure 9. 
1
H NMR spectra of the allylic hydrogen chemical shift of 7-hydroxy-4-
methylcoumarin. 
The methyl protons attached to the allylic carbon have a chemical shift at 2.34ppm. This 
chemical at 2.34ppm will be a singlet peak due to no neighboring hydrogens adjacent to the 
allylic protons. Also, the allylic proton shift is a key characteristic in the compounds synthesized 
in the research due to ethyl acetoacetate being the β-keto ester utilized in this research. If another 
β-keto ester derivative where used, there would be a difference in spectra due to a different atom 
being attached at the alkene position. The NMR solvent that was used for the NMR analysis was 
DMSO, which is responsible for the chemical shifts at 2.5ppm. The broad chemical shifts at 
3.3ppm represent waters of hydration. 
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Figure 10. 
1
H NMR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione. 
4.3.3 Discussion of the thione spectra. As seen in the NMR spectra of 7 hydroxy-4-
methyl 2H-chromene-2-thione, there is a change in the chemical shifts. The allylic and phenolic 
chemical shifts in the 
1
H NMR of the thione derivative did not vary much from the 
1
H NMR 
spectra of the coumarin derivative. The chemical shift that underwent the most change was the 
vinylic hydrogen as it has shifted from 6.0-6.1ppm where it comes in on the coumarin molecule 
to 7.0-7.05ppm in the 
1
H NMR of the 2H-chromene-2-thione derivative. This indicates that the 
sulfur atom being substituted at the carbonyl, has affected this proton shift.  However, in order to 
validate this claim, 
13
C and infrared spectroscopy will be the determining factors for the 
prescence of the C=S bond, and the absence of the carbonyl stretch in the infrared spectra. 
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Figure 11. Aromatic region of the 
1
H NMR spectra of 7-hydroxy-4-methyl-2H-chromene-2-
thione. 
Figure 11 is the aromatic region of the NMR spectra. The aromatic hydrogens of the 
coumarins typically have a chemical shift around 7.0-8.0ppm, however in the chromene-2-thione 
derivative; it appears that the aromatic and vinylic hydrogen’s have switched chemical shifts. 
This may possibly be due to the sulfur atom at the 2-one position. 
There are three sets of doublets and two singlets. The pairs of doublets in the aromatic 
region of the 
1H NMR spectrum indicates that the hydrogen’s adjacent to each other on the 
aromatic ring are coupling each other. However from the J coupling value proved that this was 
inconclusive as no J coupling value was calculated for both hydrogens (see experimental 3.5.1).  
The doublet at 6.8ppm is from the lone hydrogen that has no neighboring hydrogen’s. It is 
possible that the hydrogen is being coupled as well via “W” coupling. In order to determine that 
this is occurring, there is to be observed a J coupling value of 2-3 Hz. The “W’ coupling theory 
would prove to be inconclusive as no J coupling value was obtained for the aromatic hydrogen. 
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Figure 12. 
1
H NMR spectra of the allylic hydrogen chemical shift. 
Figure 11 is the aromatic region of the NMR spectra. There are three sets of doublets and 
two singlets. The pairs of doublets in the aromatic region of the 
1
H NMR spectrum indicates that 
the hydrogen’s adjacent to each other on the aromatic ring are coupling each other. The lone 
hydrogen that has no neighboring hydrogen’s is being coupled as well via “W” coupling. The 
aromatic hydrogens of the coumarins typically have a chemical shift around 7.0-8.0ppm, 
however in the chromene-2-thione derivative; it appears that the aromatic and vinylic hydrogen’s 
have switched chemical shifts. 
Figure 12 illustrates the region of the spectra that is called the “up field” indicative of the 
shielding of hydrogens. The vinylic protons on the coumarin molecule have a shift in this region 
typically around 2.3ppm from the three methyl protons. This peak always shows up as a singlet 
in this region, however as shown in  Figure 9, there is a doublet indicating that the vinylic 
hydrogen is coupling with other hydrogens on the chromene-2-thione molecule. Table 4 shows 
the variance in the chemical shifts of the vinlyic, allylic, and phenolic protons in the 
1
H NMR 
spectra. From the data table it is seen that there isn’t much change in each chemical shift of the 
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coumarin derivatives, possibly a few points difference. However, in the 2H-chromene-2-thione 
derivatives, there is a drastic change in the chemical shifts particularly the vinylic hydrogen, 
shifting from 6.0ppm to approximately 7.0-7.1ppm and in some cases the phenolic chemical 
shifts (at 10-10.8ppm). The allylic protons on both the coumarin and 2H-chromene-2-thione 
derivative underwent the least amount of change as it didn’t experience a change in chemical 
shift in the thione derivative or the coumarin. From the change in the chemical shifts of vinylic 
protons one can possibly conclude that the carbonyl molecule was transformed into its thio 
analog. 
13
C NMR and infrared spectroscopy will be the ultimate factor to determine if the thione 
derivative was synthesized. 
Table 4 
Vinylic, Allylic and Phenolic 
1
H Chemical Shifts 
 
 
 
 
 
 
 
 
 
 
 
 
Compound Vinyllic 
1
H 
shift (ppm) 
Allylic 
1
H 
Shift 
(ppm) 
Phenolic 
1
H Shift 
(ppm) 
 
 
O = 6.10 
S = 7.02 
 
 
O = 2.35 
S = 2.35 
 
O = 10.52 
S = 12.39 
 
 
O = 6.12 
S = 8.05 
 
 
O = 2.15 
S = 2.33 
 
O = 10.41 
 
 
 
 
O = 6.08 
S = 7.08 
 
O = 2.34 
S = 5.62 
 
O = 10.46 
S = 11.76 
 
 
O = 6.20 
S = 7.09 
 
O = 2.38 
S = 2.34 
 
O = 7.70, 7.68 
S = 8.83; 8.94 
 
 
O = 6.10 
S = 7.23 
 
O = 2.33 
S = 2.09 
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4.3.4 Discussion of the carbon 13 spectra of coumarin. As stated previously, to 
determine if the thio analogs have successfully been synthesized, the determining factor will be 
the 
13
C NMR spectra. According to the referenced literature (indicated by the asterisk in the 
table) for the allylic, vinylic, and carbonyl chemical shifts will fall within range of 18-24, 110-
112 and 155-162ppm (Karimi & Zareyee, 2008). Table 5 provides a quantitative analysis of the 
chemical shifts of the various carbons on the coumarin molecule and the environments they are 
in. The allylic, vinylic, and carbonyl shifts of the coumarin were compared to the thio analogs. 
As seen from the table there wasn’t a drastic change in the allylic, and vinylic carbons of the 
coumarin molecule and thio derivatives. However, the chemical shift of the carbonyl carbon has 
shifted downfield in most of the thio derivatives (with the exception of 6-chloro 7-hydroxy 4-
methyl 2H-chromene-2-thione) from approximately 160ppm to 197 and further downfield at 
206ppm in some thio derivatives. However, the chemical shift of the carbonyl carbon has shifted 
downfield in most of the thio derivatives (with the exception of 6-chloro 7-hydroxy 4-methyl 
2H-chromene-2-thione) from approximately 160ppm to 197 and further downfield at 206ppm in 
some thio derivatives.  
When compared to referenced literature for the thio analogs, spectral data of the thio 
analogs synthesized in this research correlate to the chemical shifts of the new carbon-sulfur 
double bond that is formed during the transformation of the coumarin derivatives. From the 
experimental analysis of S. Kumar, B. Singh, and N. Kalra et al. the carbon-sulfur double bond is 
expected to fall within the range of 195-200ppm respectively (Kumar et al., 2005). Table 5 
shows the chemical shifts of the thio derivatives all have a carbonyl shift of approximately 195-
200ppm; whereas in the coumarin derivatives the chemical shift was 155-162ppm. With this 
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significant change in the chemical shift of the carbonyl carbon the conclusion can be drawn that 
the 2H-chromene-2-thione derivatives were successfully synthesized. 
 From the 
13
C spectra of 6-chloro-7-hydroxy 4-methylcoumarin it seemed as though the 
transformation of the coumarin derivative into the 2H-chromene-2-thione derivative did not take 
place due to the chemical shift of the carbonyl carbon (157.76ppm) compared to the coumarin 
carbonyl shift of 160.8ppm. This could revert back to the factor of the solubility of the reagent 4-
chloro resorcinol. Infrared spectroscopy would validate this statement with the absence of the 
C=S band in the spectra.  
Table 5 
Vinylic, Allylic and Carbonyl Carbon 
13
C Chemical Shifts 
Compound Allylic 
13
C 
shift (ppm) 
Vinylic 
13
C Shift 
(ppm) 
Carbonyl 
13
C 
Shift (ppm) 
 
 
O = 18.48* 
S = 19.50 
 
 
O = 113.24* 
S = 105.60 
 
O = 161.56* 
S = 195.90 
 
 
O = 18.57* 
S = 17.19 
 
 
O = 112.36* 
S = 100.36 
 
O = 160.83* 
S = 197.55 
 
 
 
O = 19.40* 
S = 20.64 
 
O = 112.50* 
S = 112.46 
 
O = 160.80* 
S = 157.76 
 
 
O = 19.40* 
S = 22.67 
 
O = 112.50* 
S = 102.54 
 
O = 160.80* 
S = 197.25 
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Table 5 
Cont. 
 
Figure 13. 
13
C NMR spectra of 7-hydroxy-4,8-dimethylcoumarin (Karimi & Zareyee, 2008). 
Compound Allylic 
13
C 
shift (ppm) 
Vinylic 
13
C Shift 
(ppm) 
Carbonyl 
13
C 
Shift (ppm) 
 
 
O = 18.66* 
S = 20.68 
 
O = 112.55* 
S = 116.42 
 
O = 160.64* 
S = 199.31* 
 
 
O = 18.58* 
S = 17.18 
 
O = 112.55* 
S = 100.39 
 
O = 162.81* 
S = 206.46 
 
 
O = 23.87* 
S = 26.32 
 
O = 109.25* 
S = 154.35 
 
O = 155.41* 
S = 206.67 
 
 
O = 23.70* 
S = 26.32 
 
O = 112.50* 
S = 112.74 
 
O = 160.8* 
S = 200.96 
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Figure 14. 
13
C NMR spectra of 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione. 
4.3.5 Discussion of the thione carbon 13 spectra. To provide an illustration of Table 5, 
figure 13 is the 
13
C spectra of 7-hydroxy-4-methylcoumarin (Karimi & Zareyee, 2008). The 
peaks that are of interest in this research are the allylic vinylic and phenolic carbon peaks. 
Variance in the chemical shifts of these three peaks of in coumarin and thione derivatives were 
observed. The carbonyl carbon on the coumarin molecule is expected to undergo the most 
change as a sulfur atom is being substituted for an oxygen atom. Shown in the spectra, the 
allylic, vinylic, and carbonyl chemical shifts are 18.57, 110.30 (the alkene carbon closest to the 
oxygen atom) and 160.83ppm. Figure 14 is the 
13
C spectra of 7-hydroxy-4-methyl-2H-
chromene-2-thione. As seen in the spectra, the chemical shift of the carbonyl carbon underwent 
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the most change shifting from 160.83 to 201.56ppm. From the quantitative analysis shown in 
table 5, and the spectral data shown, it has been proven that the 2H-chromene-2-thione 
derivatives were synthesized.  
Table 6 
Variance of the C=S Peaks 
4.4 Discussion of the IR Spectra 
4.4.1 Infrared spectra interpretation. In order to validate the 
13
C NMR spectra of the 
thione derivatives, Infrared Spectroscopy was utilized to determine the presence of the C=S 
stretch and the absence of the C=O (carbonyl) stretch. The referenced wavelength of the 
carbonyl stretch in a pyrone molecule is around 1715 and 1775cm
-1 
(William H. Brown, 2005
)
. 
Two bands are expected in this region. According to NIST (National Institute of Standards and 
Technology) chemistry web book for vibrational energy, the C=S stretch is to show up in around 
Compound  C=S Stretch cm
-1
  
 
 
  
1218 cm-1 
 
 
  
1242 cm-1 
 
 
  
1215 cm-1 
 
 
  
1208 cm-1 
 
 
  
1238 cm-1 
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1275-1030cm
-1
.  The IR spectra of the thione derivatives synthesized in this research shows there 
is the absence of the carbonyl stretch around 1715 and 1775 cm
-1
. Table 6 quantitatively shows 
the C=S stretch of the thione derivatives. Each thione derivative within the chart has a stretch 
within 1275-1030cm-1; all were closer to the latter end (average wavelength 1225 cm-1). 
 
Figure 15. IR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione. 
Figure 15 illustrates the IR spectra of 7-hydroxy-4-methyl-2H-chromene-2-thione. As 
seen, there is a strong peak at 1218 cm-1 which is indicative of the C=S stretch. Also seen in the 
IR spectra, there is the absence of peaks in the region for pyrone carbonyls. From the validation 
of the IR spectra it has been proven that the thione derivatives were synthesized with success. 
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CHAPTER 5 
Discussion and Future Research 
From the NMR and IR analysis, it was proven that the 2H-Chromeme-2-Thione 
derivatives were indeed synthesized. The key factor in this determination was the vinylic 
hydrogen chemical shift in the 
1
H NMR, the chemical shift of the carbonyl carbon in the 
13
C 
spectra and the absence of the carbonyl stretch in the lactone molecule. As stated, the referenced 
shift for the vinylic hydrogen of the coumarin will have a chemical shift of 6.1ppm, for the 
carbonyl carbon, a chemical shift of approximately 160ppm in the 
13
C NMR and the IR stretch 
for the carbonyl in the lactone will have 2 bands around 1715 and 1775 cm
-1
. For each 2H-
chromene-2-thione synthesized there was a singlet peak around 7.0-7.1ppm and in the 
13
C NMR 
spectra, there was a chemical shift of approximately 197-200ppm for the carbonyl carbon. For 
the IR spectra, there was an absence of the lactone bands and a strong peak around 1225 cm
-1
 for 
wan indication that the C=S bond is present in the molecule. Future recommendations for this 
research are to improve upon the synthesis of the 2H-Chromeme-2-Thione derivatives and 
increase the percent yields. The protective procedure of the coumarins to be converted into the 
2H-chromene-2-thione derivatives seems to be the best strategy to successfully obtain the 2H-
chromene-2-thione-derivatives. Although the ZrCl4 catalyzed Von Pechmann condensation 
requires no solvent and is carried out at room temperature, to obtain better percent yields and 
compounds without impurities heat will be introduced during the reaction to synthesize the 
coumarins with ease. Also, other resorcinol derivatives are currently being investigated to be 
used in the synthesis of more coumarin derivatives. Recently, 2-Nitro resorcinol was investigated 
to determine if the 2H-chromene-2-thione derivative of 2-Nitro resorcinol would make for a 
cancer chemopreventive agent of interest. Procedures to synthesize the coumarin derivatives 
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containing multiple hydroxyl substituents could also be investigated. Other findings has 
concluded that 7,8-dihydroxy-4-methyl-2H-chromene-2-thione derivatives were more potent at 
inhibiting TNFα ICAM-1 expression then their respective coumarin analogs. This is said to be 
due to the fact that the hydroxyl groups can readily be converted into the quinone form (Kumar 
et al., 2005). Therefore synthesizing 2H-chromene-2-thione derivatives with multiple hydroxyl 
substituents may provide an excellent candidate as a cancer chemopreventive. The 2H-
chromene-2-thione-derivatives synthesized in this study will be sent to the NIH DTP National 
Institute of Health Developmental Therapeutics Program to be tested against 60 cancer cell lines 
to determine if the thione derivatives inhibit or retard cancer activity in vitro. Optimistically, by 
having the thio substituent attached to the coumarin molecule will have a greater effect on the 
anticancer activity of the coumarin derivatives. 
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Appendix A 
 
Figure.  
1
H NMR spectra of 7-hydroxy-4,8 –dimethylcoumarin. 
 
Figure  
1
H NMR spectra of 6-chloro-7-hydroxy-4-methylcoumarin. 
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Figure.  
1
H NMR spectra of 6-n-dodecyl-7-hydroxy-4-methylcoumarin. 
 
Figure.  
1
H NMR spectra of 7,8-dihydroxy-4-methylcoumarin. 
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Figure.  
1
H NMR spectra of 7-methoxy-4-methylcoumarin. 
 
 
Figure.  
1
H NMR spectra of 5,7-dihydroxy-4-methylcoumarin. 
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Figure.  
1
H NMR spectra of 5,7-ditertbutyldimethylsilyloxy-4-methylcoumarin. 
 
Figure.  
1
H NMR spectra of 5-tertbutyldimethylsilyloxy-4,7-dimethylcoumarin. 
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Figure.  
1
H NMR spectra of 7,8-ditertbutyldimethylsilyloxy-4-methylcoumarin. 
 
Figure.  
1
H NMR spectra of 5-hydroxy-4,7-dimethylcoumarin. 
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Appendix B 
 
Figure.  
1
H NMR spectra of 7-tertbutyldimethylsilyloxy-4,8-dimethyl-2H-chromene-2-thione. 
 
 
Figure.  
1
H NMR spectra of 6-chloro-7-hydroxy-4-methyl-2H-chromene-2-thione. 
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Figure.  
1
H NMR spectra 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione. 
 
Figure.  
1
H NMR spectra of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione. 
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Figure.  
1
H NMR spectra of 7,8-dihydroxy-4-methyl-2H-chromene-2-thione. 
 
Figure.  
1
H NMR spectra of 7-methoxy-4-methyl-2H-chromene-2-thione. 
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Figure.  
1
H NMR spectra of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione. 
 
 
Figure.  
13
C NMR spectra of 6-chloro-7-hydroxy-4-methyl-2H-chromene-2-thione. 
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Figure. 
13
C NMR spectra of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione. 
 
Figure. 
13
C NMR spectra of 5,7-dihydroxy-4-methyl-2H-chromene-2-thione. 
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Figure.  
13
C NMR spectra of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione. 
 
Figure.  
13
C NMR spectra of 7-methoxy-4-methyl-2H-chromene-2-thione. 
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Figure.  IR spectra of 6-n-dodecyl-7-hydroxy-4-methyl-2H-chromene-2-thione. 
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Figure.  IR spectra of 7-methoxy-4-methyl-2H-chromene-2-thione. 
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Figure.  IR spectra of 5-hydroxy-4,7-dimethyl-2H-chromene-2-thione. 
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Figure.  IR spectra of 7-hydroxy-4,8-dimethyl-2H-chromene-2-thione. 
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Figure.  IR spectra of 7-tertbutyldimethylsiloxy-4,8-dimethyl-2H-chromene-2-thione. 
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Figure.  IR spectra of 7,8-dihydroxy-4-methyl-2H-chromene-2-thione. 
 
 
